Ciftdemir M, Kaya M, Selcuk E, Yalniz E. Tumors of the spine. World J Orthop 2016; 7(2): 109-116 [PMID: 26925382 DOI: 10.5312/wjo.v7.i2.109]
Corresponding Author of This Article
Mert Ciftdemir, MD, Assistant Professor, Department of Orthopaedics and Traumatology, Trakya University School of Medicine, Balkan Yerleskesi, 22030 Edirne, Turkey. dr.mert@gmail.com
Research Domain of This Article
Orthopedics
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Orthop. Feb 18, 2016; 7(2): 109-116 Published online Feb 18, 2016. doi: 10.5312/wjo.v7.i2.109
Tumors of the spine
Mert Ciftdemir, Murat Kaya, Esref Selcuk, Erol Yalniz
Mert Ciftdemir, Murat Kaya, Esref Selcuk, Erol Yalniz, Department of Orthopaedics and Traumatology, Trakya University School of Medicine, 22030 Edirne, Turkey
Author contributions: Ciftdemir M wrote the manuscript, helped in literature review and making the tables, and checked the references; Kaya M, Selcuk E and Yalniz E performed the literature review and drafted the article; all authors approved the final version of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest related to the work.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Mert Ciftdemir, MD, Assistant Professor, Department of Orthopaedics and Traumatology, Trakya University School of Medicine, Balkan Yerleskesi, 22030 Edirne, Turkey. dr.mert@gmail.com
Telephone: +90-532-7653385 Fax: +90-284-2133899
Received: May 12, 2015 Peer-review started: May 18, 2015 First decision: August 19, 2015 Revised: September 20, 2015 Accepted: November 13, 2015 Article in press: November 17, 2015 Published online: February 18, 2016 Processing time: 280 Days and 7.8 Hours
Core Tip
Core tip: Primary tumors involving the spine are rare, while spinal column metastases are present in up to 70% of cancer patients. Both primary and metastatic tumors of the spine are often asymptomatic or have non-specific symptoms because in spine tumors, delayed diagnosis is not very unusual. Goal of treatment in spinal column metastases is to optimize the patient’s quality of life by providing effective pain relief and preserving or restoring neurological functions. Treatment strategy for primary tumors should be planned after both oncological and surgical staging. Because of that, biopsy is a very important step in primary tumors. Surgery in metastatic tumors are mostly palliative, aiming short-term control. Primary benign and malignant lesions mainly cause canal compromise and are treated surgically according to oncological staging and Weinstein-Boriani-Biagini classification.
